SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

7.70
Delayed Data
As of 12:25pm ET
 -0.01 / -0.13%
Today’s Change
4.24
Today|||52-Week Range
9.14
-12.10%
Year-to-Date
No recent news for SciClone Pharmaceuticals Inc.

Today’s Trading

Previous close7.71
Today’s open7.69
Day’s range7.63 - 7.76
Volume81,826
Average volume (3 months)345,992
Market cap$391.0M
Dividend yield--
Data as of 12:25pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+25.00%
Earnings growth (this year)+180.00%
Earnings growth (next 5 years)+14.70%
Revenue growth (last year)-18.69%
P/E ratio18.8
Price/Sales2.13
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...-0.14-0.85%
PTXPernix Therapeutics ...-0.06-0.55%
ACRXAcelRx Pharmaceutica...-0.02-0.22%
SUPNSupernus Pharmaceuti...-0.31-3.38%
Data as of 12:37pm ET, 02/27/2015

Financials

Next reporting dateMarch 11, 2015
EPS forecast (this quarter)$0.15
Annual revenue (last year)$127.1M
Annual profit (last year)$11.0M
Net profit margin8.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Friedhelm Blobel
Chief Financial Officer &
Senior Vice President
Wai-Shun Wilson Cheung
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account